Prevention & lipidsCohort study

Sex differences in cardiovascular disease risk and the role of biological aging pace

Eur J Prev CardiolPublished

  • Prospective cohort study
  • population-based
  • UK Biobank

Authors' conclusion

Our findings reveal that the biological aging pace might partially explain sex disparities in CVD risk

Study context

Population
UK Biobank participants
Participants
371,032 participants
Exposure
Males vs females
Outcome
CVD risk by sex and proportion explained by biological aging pace (PhenoAgeAccel, telomere length)

Main finding

As reported in the abstract

CVD risk by sex and share explained by biological aging pace (PhenoAgeAccel)
Any cardiovascular disease (CVD), male vs female participants, HR
1.66 (1.54-1.80) (95% CI)
AF, male vs female participants, HR
1.78 (1.73-1.83) (95% CI)
CHD, male vs female participants, HR
2.11 (2.05-2.18) (95% CI)
HF, male vs female participants, HR
1.72 (1.65-1.80) (95% CI)
Stroke, male vs female participants, HR
1.44 (1.38-1.51) (95% CI)
Females' longer time to CVD than males
0.71-2.90 years
Males' faster biological aging pace in PhenoAgeAccel than females
1.02 years (95% CI 0.99-1.06)
Share of male-associated any CVD explained by sex disparities in PhenoAgeAccel
65.0%
Share of male-associated AF explained
64.7%
Share of male-associated CHD explained
68.2%
Share of male-associated HF explained
64.4%
Share of male-associated stroke explained
60.4%

Observational data: associations, not effects.

Further findings

Chronological age

Outcomedifference (years) (95% CI)
PhenoAgeAccel (biological aging pace) · faster in males1.02 (0.99–1.06)
PhenoAgeAccel (biological aging pace) — Explained by unhealthy lifestyles
17.1%
PhenoAgeAccel (biological aging pace) — Explained by prevalent chronic diseases
8.6%
PhenoAgeAccel (biological aging pace) — Explained by metabolic factors
6.5%

Time to CVD

Females had longer time to CVD than males
0.71-2.90 years

Telomere length; adjustment for sex hormones

Similar findings

Original publication

Sex differences in cardiovascular disease risk and the role of biological aging pace. Eur J Prev Cardiol. Published 11 December 2025. doi:10.1093/eurjpc/zwaf726

Summarised from the published abstract; every number is checked against it